Acoltremon ophthalmic solution effectively increases tear production for dry eye disease, demonstrating benefits and a favorable safety profile in clinical trials.
Ava Landry, PharmD Candidate
Advertisement
Articles by Ava Landry, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Bipartisan Legislation Aims to Address Consolidation and Vertical Integration of PBMs
2
FDA Removes Black Box Warning on 6 Menopausal Hormone Therapy Products
3
The Evolution of DTP Pharmacy Models and the Future of Digital Health
4
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies
5